Preemption Summary Judgment Granted In Herceptin MDL About Misleading Vial Volume

Mealey's (March 29, 2019, 6:05 PM EDT) -- TULSA, Okla. — The Oklahoma federal judge presiding over the Herceptin multidistrict litigation on March 20 granted summary judgment to defendant Genentech Inc. after finding that the complaints by cancer treatment...
To view the full article, register now.